Global Finance Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Finance Herald.

Press releases published on September 30, 2026

Sep. 30, 2026

FactSet Reports Results for Fourth Quarter and Fiscal 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Indeterminate GlobeNewswire

Sep. 30, 2026

10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher

Indeterminate GlobeNewswire

Sep. 30, 2026

Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer

Indeterminate GlobeNewswire

Sep. 30, 2026

Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

Indeterminate GlobeNewswire

Sep. 30, 2026

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Northland Power Closes Financing for Two Battery Storage Projects in Poland

Indeterminate GlobeNewswire

Sep. 30, 2026

ONAR Completes Largest Acquisition in Company History: Advertise Purple Adds $17.1 Million of Revenue and $4.4 Million of Net Income, Bringing Combined Pro Forma Revenue to Approximately $23.5 Million

Indeterminate GlobeNewswire

Sep. 30, 2026

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Indeterminate GlobeNewswire

Sep. 30, 2026

Beamr Expects Fiscal Year 2026 Revenues to Increase by $1.5 Million Year Over Year

Indeterminate GlobeNewswire

Sep. 30, 2026

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

Indeterminate GlobeNewswire

Sep. 30, 2026

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Indeterminate GlobeNewswire

Sep. 30, 2026

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

Indeterminate GlobeNewswire

Sep. 30, 2026

Enigmatig Limited Issues Statement on Recent Share Trading Activity

Indeterminate GlobeNewswire

Sep. 30, 2026

YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs

Indeterminate GlobeNewswire

Sep. 30, 2026

YieldMax® ETFs Announces Quarterly Distribution for the U.S. Stocks Target Double Distribution ETF (DDDD)

Indeterminate GlobeNewswire

Sep. 30, 2026

Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA

Indeterminate GlobeNewswire

Sep. 30, 2026

MAPFRE Brazil Increases Customer Retention from 1% to 40% and Protects Revenue within 60 Days of Implementing SuccessKPI AI-Powered Quality Management

Indeterminate GlobeNewswire

Sep. 30, 2026

Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum

Indeterminate GlobeNewswire

Sep. 30, 2026

Sucden Financial Appoints James Wheaton as Deputy Head of Softs

Indeterminate GlobeNewswire